|Datasheet||Specific References||Reviews||Related Products||Protocols|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Ferret CD20 / MS4A1 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||FG60004-G-F|
|Ferret CD20 / MS4A1 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||FG60004-G-H|
|Ferret CD20 / MS4A1 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||FG60004-G-M|
|Ferret CD20 / MS4A1 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||FG60004-G-N|
|Ferret CD20 / MS4A1 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||FG60004-G-Y|
CD20 (membrane-spanning 4-domains, subfamily A, member 1), also known as MS4A1, is a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. CD20 / MS4A1 is expressed on all stages of B cell development except the first and last. CD20 / MS4A1 is present from pre-pre B cells through memory cells, but not on either pro-B cells or plasma cells. It is a B-lymphocyte surface molecule which plays a role in the development and differentiation of B-cells into plasma cells. CD20 / MS4A1may be involved in the regulation of B-cell activation and proliferation. Defects in CD20 / MS4A1 are the cause of immunodeficiency common variable type 5(CVID5). CVID5 is a primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.